CA2372164A1 - Synthese chimique et utilisation de domaines de recepteurs de proteines membranaires solubles - Google Patents
Synthese chimique et utilisation de domaines de recepteurs de proteines membranaires solubles Download PDFInfo
- Publication number
- CA2372164A1 CA2372164A1 CA002372164A CA2372164A CA2372164A1 CA 2372164 A1 CA2372164 A1 CA 2372164A1 CA 002372164 A CA002372164 A CA 002372164A CA 2372164 A CA2372164 A CA 2372164A CA 2372164 A1 CA2372164 A1 CA 2372164A1
- Authority
- CA
- Canada
- Prior art keywords
- receptor
- extramembranous
- domain
- ligand
- membrane protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/006—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1075—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of amino acids or peptide residues
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
- C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/13—Labelling of peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/72—Receptors; Cell surface antigens; Cell surface determinants for hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Analytical Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Cell Biology (AREA)
- Endocrinology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Peptides Or Proteins (AREA)
Abstract
La présente invention concerne la synthèse chimique de domaines de récepteurs extramembranaires de récepteurs de protéines membranaires, et des compositions et des méthodes les utilisant. Les domaines de récepteurs extramembranaires comprennent les domaines cytosoliques et extracellulaires de liaison de ligands solubles de récepteurs de protéines membranaires. On produit les domaines de récepteur extramembranaire de l'invention en ligaturant dans des conditions chemosélectives de ligature chimique des premier et second peptides d'un domaine de récepteur extramembranaire d'un récepteur de protéine membranaire, où les peptides présentent des groupes réactifs chemosélectifs non protégés pouvant former une liaison covalente. Le produit de ligature est exposé à un tampon de pliage comportant un réactif chaotropique et un solvant organique se rapprochant de l'interface eau-lipide d'une membrane cellulaire. L'exposition au tampon de pliage est suivie par l'isolation du tampon de produit de ligature se fixant à un ligand du récepteur de protéine membranaire. La partie de fixation de ligand du produit de ligature produite par cette méthode représente un domaine de récepteur extramembranaire plié. L'invention est illustrée par la synthèse chimique totale du domaine N-terminal du récepteur de peptide-1 semblable au glucagon, par la démonstration de sa capacité à se fixer au ligand de peptide et par la caractérisation de sa carte bisulfure.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12427299P | 1999-03-11 | 1999-03-11 | |
US60/124,272 | 1999-03-11 | ||
PCT/US2000/006297 WO2000053624A1 (fr) | 1999-03-11 | 2000-03-09 | Synthese chimique et utilisation de domaines de recepteurs de proteines membranaires solubles |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2372164A1 true CA2372164A1 (fr) | 2000-09-14 |
Family
ID=22413849
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002372164A Abandoned CA2372164A1 (fr) | 1999-03-11 | 2000-03-09 | Synthese chimique et utilisation de domaines de recepteurs de proteines membranaires solubles |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1159289A1 (fr) |
JP (1) | JP2002539136A (fr) |
CN (1) | CN1350544A (fr) |
AU (1) | AU768118B2 (fr) |
CA (1) | CA2372164A1 (fr) |
HK (1) | HK1046534A1 (fr) |
WO (1) | WO2000053624A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007004060A3 (fr) * | 2005-05-05 | 2007-04-26 | Valorisation Hsj Soc En Comman | Modulateurs du recepteur de la cytokine et leurs utilisations |
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482425B2 (en) | 1999-08-26 | 2009-01-27 | Amylin Pharmaceuticals, Inc. | Compositions for lipid matrix-assisted chemical ligation |
KR20020097241A (ko) | 2000-05-04 | 2002-12-31 | 에이브이아이 바이오파마 인코포레이티드 | 스플라이스-영역 안티센스 조성물 및 방법 |
US7785834B2 (en) | 2005-11-10 | 2010-08-31 | Ercole Biotech, Inc. | Soluble TNF receptors and their use in treatment of disease |
CA2666981A1 (fr) * | 2006-10-20 | 2008-05-02 | Ercole Biotech, Inc. | Recepteurs de tnf solubles et leur utilisation pour le traitement de maladies |
US8637452B2 (en) * | 2011-02-23 | 2014-01-28 | Massachusetts Institute Of Technology | Water soluble membrane proteins and methods for the preparation and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1995003321A1 (fr) * | 1993-07-20 | 1995-02-02 | Bionebraska, Inc. | Procede d'endomodification de proteins |
ATE354584T1 (de) * | 1997-06-13 | 2007-03-15 | Gryphon Therapeutics Inc | Festphasige native chemische ligation von ungeschützten oder n-cystein-geschützten peptiden in wässrigen lösungen |
-
2000
- 2000-03-09 AU AU38748/00A patent/AU768118B2/en not_active Ceased
- 2000-03-09 WO PCT/US2000/006297 patent/WO2000053624A1/fr active IP Right Grant
- 2000-03-09 CA CA002372164A patent/CA2372164A1/fr not_active Abandoned
- 2000-03-09 JP JP2000604059A patent/JP2002539136A/ja active Pending
- 2000-03-09 CN CN00807439A patent/CN1350544A/zh active Pending
- 2000-03-09 EP EP00917838A patent/EP1159289A1/fr not_active Withdrawn
-
2002
- 2002-11-12 HK HK02108186.5A patent/HK1046534A1/zh unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8618054B2 (en) | 2004-05-05 | 2013-12-31 | Valorisation-Rechereche Société en Commandite | Interleukin-1 receptor antagonists, compositions, and methods of treatment |
WO2007004060A3 (fr) * | 2005-05-05 | 2007-04-26 | Valorisation Hsj Soc En Comman | Modulateurs du recepteur de la cytokine et leurs utilisations |
Also Published As
Publication number | Publication date |
---|---|
AU3874800A (en) | 2000-09-28 |
JP2002539136A (ja) | 2002-11-19 |
EP1159289A1 (fr) | 2001-12-05 |
HK1046534A1 (zh) | 2003-01-17 |
WO2000053624A1 (fr) | 2000-09-14 |
CN1350544A (zh) | 2002-05-22 |
AU768118B2 (en) | 2003-12-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6451543B1 (en) | Lipid matrix-assisted chemical ligation and synthesis of membrane polypeptides | |
Sewald et al. | Peptides: chemistry and biology | |
Offer et al. | N α-2-Mercaptobenzylamine-assisted chemical ligation | |
Zheng et al. | Expedient total synthesis of small to medium-sized membrane proteins via Fmoc chemistry | |
Liu et al. | Chemical synthesis of peptides within the insulin superfamily | |
Bao et al. | Highly efficient expression and purification system of small-size protein domains in Escherichia coli for biochemical characterization | |
Hossain et al. | Novel methods for the chemical synthesis of insulin superfamily peptides and of analogues containing disulfide isosteres | |
Wu et al. | Synthesis of four-disulfide insulin analogs via sequential disulfide bond formation | |
ES2896100T3 (es) | Dominio FKBP con sitio de reconocimiento de transglutaminasa | |
Crone et al. | Modulation of coiled-coil binding strength and fusogenicity through peptide stapling | |
AU768118B2 (en) | Chemical synthesis and use of soluble membrane protein receptor domains | |
Wang et al. | Chemical Synthesis of diSUMO Photoaffinity Probes for the Identification of PolySUMO Chain-Specific Interacting Proteins | |
Das et al. | Peptaibols as a Model for the Insertions of Chemical Modifications | |
JP2003527561A (ja) | 蛋白の部位特異的標識化方法およびそのための使用 | |
US7482425B2 (en) | Compositions for lipid matrix-assisted chemical ligation | |
Umanah et al. | Cross-linking of a DOPA-containing peptide ligand into its G protein-coupled receptor | |
US20130143251A1 (en) | Expeditious synthesis of ubiquitinated peptide conjugates | |
AU2002336501A1 (en) | Modular peptide-based reagent | |
Zou et al. | Biosynthesis and NMR-studies of a double transmembrane domain from the Y4 receptor, a human GPCR | |
Naider et al. | The synthesis of sulfated CCR5 peptide surrogates and their use to study receptor-ligand interactions | |
Dong et al. | Design and Synthesis of Cross-Link-Dense Peptides by Manipulating Regioselective Bisthioether Cross-Linking and Orthogonal Disulfide Pairing | |
Grygiel et al. | Synthesis by native chemical ligation and crystal structure of human CCL2 | |
Nokihara et al. | Chemical synthesis of Maxadilan, a non-mammalian potent vasodilatory peptide consisting of 61 amino acids with two disulfide bridges, and its related peptides | |
Szolomajer et al. | Synthesis of the extracellular domain of GLP-1R by chemical and biotechnological approaches | |
Warner | Multifunctionalization of proteins: Strategies for combining semi-synthetic and bioorthogonal techniques |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |